TGFB1 and neoplasm: Additionally, blocking miR-941 transfer from TANs to tumor cells could be achieved through exosome-mediated strategies, such as using exosomal inhibitors (e.g., GW4869) or engineering exosomes to deliver FOXN4 mRNA or TGF-β pathway antagonists.